NEW YORK (GenomeWeb) – PathoQuest, an Institut Pasteur spinout, said today that it has received CE marking for iDTECT Blood, a next-generation sequencing-based metagenomics test for blood pathogens.

The "sample-to-report" test is designed to detect bacteria and viruses in blood samples from patients with suspected infections, especially immunocompromised patients, PathoQuest said.

With the CE mark, PathoQuest will now offer the test through an early-access program in selected countries, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.